Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 2,615 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Sleep-Wake Disorders Clear all

Conditions: Obstructive Sleep Apnea
Interventions: AD036, Atomoxetine, Placebo; Drug
Lead sponsor: Apnimed; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 5
States / cities: Little Rock, Arkansas • Santa Ana, California • Chevy Chase, Maryland + 2 more

Conditions: Shift Work Type Circadian Rhythm Sleep Disorder, Insomnia, Psychophysiological
Interventions: Shift Worker Intervention for Sleep Health; Behavioral
Lead sponsor: Oregon State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Corvallis, Oregon

Conditions: Inappropriate Prescribing
Interventions: Z-drug Default Quantity, Redirection + Accountable Justification; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Menopause Related Conditions
Interventions: Sleepwear with Lateralized Thermal Characteristics, Sham-Lateralized Sleepwear; Device
Lead sponsor: St. Peter's Hospital, Albany, NY; Other
Eligibility: 40 Years to 69 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Albany, New York

Conditions: Obstructive Sleep Apnea
Interventions: Tailored Videos, OSA Treatment, Standard Videos; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Insomnia
Interventions: mind body treatment, desensitization; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 59 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Cardiovascular Diseases Risk, Cardiac Conduction System Disease, Bundle/Fascicular Abnormalities, His-Purkinje Disease, Arrhythmias, Cardiac, Rhythm Phenotypes, Myocardial Ischemia, Syncope, Syncope Recurrent, Syncope and Collapse, Seizure Disorder, Sleep Apnea Syndrome, Obstructive, Decision Support Systems, Clinical, Heart Failure - NYHA II - IV, Heart Failure (for Example, Fluid Overload), HRV, Cardiopulmonary, Sudden Cardiac Arrest, Cardiac Arrest (CA), Ventricular Arrhythmias and Cardiac Arrest, Ventricular Fibrillation, QT Dispersion, Atrial Cardiomyopathy
Interventions: COR Wearable ECG Monitoring, Cor360 Clinician-Facing Decision-Aid Reporting; Device · Other
Lead sponsor: Peerbridge Health, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Pasadena, California • Nashville, Tennessee

Conditions: Post-Traumatic Stress Disorder
Interventions: Carvedilol, Placebo; Drug
Lead sponsor: Columbia Northwest Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: San Diego, California • Lake Charles, Louisiana • Bellevue, Washington

Conditions: Sleep Deprivation, Nutritional Intervention
Interventions: Ketogenic Intervention, Mediterranean Intervention, Placebo, Ketone Ester; Other · Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Depression in Old Age
Interventions: Endotoxin, Placebo; Biological
Lead sponsor: Michael Irwin, MD; Other
Eligibility: 60 Years to 80 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Insomnia
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Depression, Insomnia
Interventions: Cognitive Behavioral Therapy for insomnia and depression; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 12 Years to 20 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Berkeley, California • Portland, Oregon

Conditions: Jet Lag
Interventions: Hydrocortisone, Melatonin, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Insomnia
Interventions: Daridorexant 10 mg, Daridorexant 25 mg, Daridorexant 50 mg, Placebo; Drug
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 12
States / cities: Tucson, Arizona • Little Rock, Arkansas • Brandon, Florida + 8 more

Conditions: Stress Reaction, Sleep Disturbance, Craving, Obesity
Interventions: Ashwagandha Root Extract Capsule, Placebo Capsule; Dietary Supplement · Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Sleep Disorder, Shift-Work
Interventions: Suvorexant, Placebo; Drug
Lead sponsor: VA Palo Alto Health Care System; Federal
Eligibility: 20 Years to 60 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Sleep Initiation and Maintenance Disorders
Interventions: EVT 201; Drug
Lead sponsor: Evotec Neurosciences GmbH; Industry
Eligibility: 21 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 5
States / cities: St. Petersburg, Florida • Atlanta, Georgia • Overland Park, Kansas + 2 more

Conditions: Neck Pain, Sleep Disturbance
Interventions: Dry Needling, Therapeutic Exercise; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Autism Spectrum Disorder
Interventions: Melatonin and Donepezil, Placebo; Drug · Other
Lead sponsor: Stony Brook University; Other
Eligibility: 4 Years to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Restless Legs Syndrome
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Insomnia
Interventions: PUMAS; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Sleep Disordered Breathing, Alzheimer's Disease
Interventions: Continuous positive airway pressure (CPAP); Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 50 Years and older
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: New York, New York

Conditions: Sleep Apnea, Obstructive
Interventions: Under-mattress sleep monitor; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 22 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Osteoarthritis, Knee, Quality of Life, Poor Quality Sleep, Physical Impairment
Interventions: Hatha Yoga; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 65 Years to 86 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Crossover Trial of AD036 in Obstructive Sleep Apnea

Shift Worker Intervention for Sleep Health

The Study in Outpatient Medicine Using Nudges to Improve Sleep

The Effects of Lateralized Thermal Sleepwear on Sleep, Skin Temperature and Skin Moisture in Menopausal Women

Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks

Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia

Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways

Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)

Ketone Conferred Resiliency Against Sleep Restriction With Nutritional Intervention.

Sleep and Healthy Aging Research for Depression (SHARE-D) Study

Transcranial Magnetic Stimulation for Treatment of Insomnia

Young Adult and Teen Sleep Study

Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Functional Assessment of Ashwagandaha Root Extract During Weight Loss

Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers

Efficacy Study of EVT 201 to Treat Insomnia

Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance

Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders

Glutamate, Hyperarousal and Restless Legs Syndrome

Telemedicine Mindfulness-based Therapy for Perinatal Insomnia: An Open-label Trial.

Sleep, Aging and Risk for Alzheimer's Disease

Evaluating an Under-mattress Sleep Monitor Compared to a Peripheral Arterial Tonometry Device in the Diagnosis of Obstructive Sleep Apnea

Yoga for Managing Knee Osteoarthritis in Older Women: a Feasibility Study